Effect of Body Mass Index on Bleeding Frequency and Activated Partial Thromboplastin Time in Weight-Based Dosing of Unfractionated Heparin: A Retrospective Cohort Study
- 31 December 2009
- journal article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 84 (12), 1073-1078
- https://doi.org/10.4065/mcp.2009.0220
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic
This publication has 22 references indexed in Scilit:
- Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesitySurgery for Obesity and Related Diseases, 2008
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation, 2007
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation, 2004
- Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studiesAmerican Heart Journal, 2003
- Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive HeparinCirculation, 2003
- Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial InfarctionCirculation, 1996
- Computer-Assisted Dosing of HeparinArchives of Internal Medicine, 1994
- The Weight-based Heparin Dosing Nomogram Compared with a Standard Care NomogramAnnals of Internal Medicine, 1993
- A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapyAmerican Journal Of Medicine, 1990
- Heparin therapy in venous thromboembolismAmerican Journal Of Medicine, 1981